Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bayer Consumer Care (Ex-North America Rights)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Rights to develop and commercialize ATX-101, a drug for facial fat reduction, outside the US and Canada. ATX-101 is a proprietary injectable formulation of a synthetic version of deoxycholic acid for the reduction of submental fat (double chin).

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Commercial Services
Primary Office
  • Peter Merian Strasse 84
  • Post Office Box
  • 4002 Basel
  • Switzerland

Bayer Consumer Care (Ex-North America Rights) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bayer Consumer Care (Ex-North America Rights)‘s full profile, request access.

Request full access to PitchBook

Bayer Consumer Care (Ex-North America Rights) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Bayer Consumer Care (Ex-North America Rights)‘s full profile, request access.

Request full access to PitchBook